Wellbutrin is not an antipsychotic. It is an antidepressant, specifically classified as an aminoketone antidepressant. The FDA has approved it for three uses: treating depression, treating seasonal affective disorder, and helping with smoking cessation. While it sometimes gets confused with other psychiatric medications, it works in a fundamentally different way than antipsychotics do.
How Wellbutrin Works vs. Antipsychotics
The confusion likely comes from the fact that both Wellbutrin and antipsychotics affect dopamine, a brain chemical involved in mood, motivation, and pleasure. But they do opposite things to it.
Wellbutrin (bupropion) works by blocking the reabsorption of dopamine and norepinephrine, keeping more of these chemicals active in the brain. It has no meaningful effect on serotonin, and it does not bind to or block dopamine receptors. This makes it a norepinephrine-dopamine reuptake inhibitor, or NDRI. Antipsychotics, by contrast, work primarily by blocking dopamine receptors. That receptor-blocking action is what reduces psychotic symptoms like hallucinations and delusions. Wellbutrin has no appreciable affinity for dopamine receptors, serotonin receptors, histamine receptors, or acetylcholine receptors, so it simply cannot produce antipsychotic effects.
Different Side Effect Profiles
The distinction between Wellbutrin and antipsychotics becomes especially clear when you compare their side effects. Antipsychotic medications are well known for causing weight gain. In one study, about 39% of patients on antipsychotics experienced clinically significant weight gain over 24 weeks. Wellbutrin goes in the opposite direction: it is the only antidepressant identified as having no risk for weight gain, and it actually tends to cause modest weight loss. In a large trial, 19 to 22% of patients on bupropion lost 7% or more of their body weight, while only about 8% gained that much.
Antipsychotics also commonly cause sedation, metabolic changes, and movement-related side effects. Wellbutrin’s most common side effects lean the other way: insomnia, dry mouth, and restlessness. This profile is what you’d expect from a drug that increases dopamine and norepinephrine activity rather than blocking it.
What Wellbutrin Is Actually Prescribed For
Beyond its three FDA-approved uses, Wellbutrin is prescribed off-label for a surprisingly wide range of conditions. It is considered a preferred antidepressant for mild-to-moderate depression in bipolar disorder because it carries a lower risk of triggering manic episodes compared to other antidepressants like tricyclics. It is also used to treat ADHD in adults, where one study found 76% of patients on bupropion reported improvement in symptoms compared to 37% on placebo.
Wellbutrin is frequently added to SSRIs (like Prozac or Zoloft) to treat sexual side effects those drugs can cause. It has shown effectiveness for sexual dysfunction even in people who aren’t depressed. Other off-label uses include PTSD, neuropathic pain, social anxiety, and reducing cravings related to cocaine or methamphetamine use.
Why Wellbutrin and Antipsychotics Are Sometimes Prescribed Together
If your provider has prescribed Wellbutrin alongside an antipsychotic, that might be another reason for the confusion. This combination is not uncommon, especially in people being treated for depression who also take an antipsychotic as an add-on. One reason Wellbutrin gets paired with antipsychotics is the hope that its weight-loss tendency might offset antipsychotic-related weight gain, though research suggests that adding bupropion does not actually mitigate the weight gain risk from antipsychotics. More often, the two are combined because they target different symptoms: the antipsychotic may address psychotic features or serve as a mood stabilizer, while Wellbutrin targets depressive symptoms and low energy.
Can Wellbutrin Cause Psychotic Symptoms?
This is an important nuance. Even though Wellbutrin is not an antipsychotic and does not treat psychosis, it can, in rare cases, trigger psychotic symptoms. The FDA label notes that patients treated with bupropion have reported hallucinations, delusions, paranoia, and confusion. These neuropsychiatric symptoms have occurred in patients both with and without pre-existing psychiatric conditions, and in most reported cases they resolved when the dose was reduced or the medication was stopped.
The risk is higher for people with undiagnosed bipolar disorder. Like all antidepressants, Wellbutrin can precipitate manic episodes in people with bipolar disorder, and it may activate latent psychosis in susceptible individuals. This is why providers are advised to screen for bipolar disorder before starting any antidepressant, including gathering a detailed personal and family psychiatric history. That said, among all antidepressants, bupropion carries one of the lowest rates of triggering a manic switch.
Seizure Risk at High Doses
One safety concern unique to Wellbutrin is a dose-related seizure risk. At doses up to 300 mg per day of the sustained-release formulation, the seizure incidence is about 0.1%, or 1 in 1,000 patients. That risk jumps nearly tenfold if the dose exceeds 450 mg per day. The maximum recommended dose for the extended-release version is 450 mg daily. Bupropion is not recommended for anyone with a history of seizures, anorexia nervosa, or bulimia, as these conditions further increase seizure risk.